Agentix Corp (AGTX)
0.0322
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
Agentix Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| August 31, 2021 | 0.00 |
| May 31, 2021 | 0.00 |
| February 28, 2021 | 0.00 |
| November 30, 2020 | 0.00 |
| May 31, 2020 | 0.00 |
| February 29, 2020 | 0.00 |
| November 30, 2019 | 0.00 |
| August 31, 2019 | -0.8719 |
| May 31, 2019 | -0.9957 |
| February 28, 2019 | -1.005 |
| November 30, 2018 | -0.8505 |
| August 31, 2018 | -0.861 |
| May 31, 2018 | -0.4779 |
| Date | Value |
|---|---|
| February 28, 2018 | -0.9696 |
| November 30, 2017 | -1.062 |
| August 31, 2017 | -1.036 |
| May 31, 2017 | -1.256 |
| February 28, 2017 | -0.0652 |
| November 30, 2016 | -0.1056 |
| August 31, 2016 | 0.00 |
| May 31, 2016 | 0.00 |
| February 29, 2016 | 0.00 |
| November 30, 2015 | 0.00 |
| August 31, 2015 | 0.00 |
| May 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.9957
Minimum
May 2019
--
Maximum
Nov 2019
-0.2075
Average
--
Median
Nov 2019
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |
| IGC Pharma Inc | 0.0152 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Protalix BioTherapeutics Inc | 0.6033 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.112M |
| Total Liabilities (Quarterly) | 2.958M |
| Shareholders Equity (Quarterly) | -2.846M |